title: Isolation and quantification of botulinum neurotoxin from complex matrices using the BoTest matrix assays.
abstract: Accurate detection and quantification of botulinum neurotoxin (BoNT) in complex matrices is required for pharmaceutical, environmental, and food sample testing. Rapid BoNT testing of foodstuffs is needed during outbreak forensics, patient diagnosis, and food safety testing while accurate potency testing is required for BoNT-based drug product manufacturing and patient safety. The widely used mouse bioassay for BoNT testing is highly sensitive but lacks the precision and throughput needed for rapid and routine BoNT testing. Furthermore, the bioassay's use of animals has resulted in calls by drug product regulatory authorities and animal-rights proponents in the US and abroad to replace the mouse bioassay for BoNT testing. Several in vitro replacement assays have been developed that work well with purified BoNT in simple buffers, but most have not been shown to be applicable to testing in highly complex matrices. Here, a protocol for the detection of BoNT in complex matrices using the BoTest Matrix assays is presented. The assay consists of three parts: The first part involves preparation of the samples for testing, the second part is an immunoprecipitation step using anti-BoNT antibody-coated paramagnetic beads to purify BoNT from the matrix, and the third part quantifies the isolated BoNT's proteolytic activity using a fluorogenic reporter. The protocol is written for high throughput testing in 96-well plates using both liquid and solid matrices and requires about 2 hr of manual preparation with total assay times of 4-26 hr depending on the sample type, toxin load, and desired sensitivity. Data are presented for BoNT/A testing with phosphate-buffered saline, a drug product, culture supernatant, 2% milk, and fresh tomatoes and includes discussion of critical parameters for assay success.
authors.affiliation: BioSentinel Inc., Madison, WI.
authors.forename: F Mark
authors.initials: FM
authors.lastname: Dunning
authors.affiliation: BioSentinel Inc., Madison, WI.
authors.forename: Timothy M
authors.initials: TM
authors.lastname: Piazza
authors.affiliation: BioSentinel Inc., Madison, WI.
authors.forename: Füsûn N
authors.initials: FN
authors.lastname: Zeytin
authors.affiliation: BioSentinel Inc., Madison, WI; wtucker@biosentinelpharma.com.
authors.forename: Ward C
authors.initials: WC
authors.lastname: Tucker
mesh_terms: D000818:Animals; D001905:Botulinum Toxins / Q000302:isolation & purification*; D045424:Complex Mixtures / Q000032:analysis*; D057166:High-Throughput Screening Assays / Q000379:methods; D051379:Mice
chemical_list: D045424:Complex Mixtures; D001905:Botulinum Toxins